ACT for Individuals With MNCD and Their Care Partners
ACT
Acceptance and Commitment Therapy for Individuals With MNCD and Their Care Partners: An In-Person and Telehealth Individual Therapy Approach
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
This project aims to implement and evaluate a dyadic intervention (i.e., acceptance commitment therapy) for persons with AD/ADRD and their care partners. We hypothesize the intervention will be feasible, acceptable, and show preliminary efficacy of the dyadic interveniotns.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Jan 2026
Typical duration for phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2025
CompletedFirst Posted
Study publicly available on registry
November 20, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
November 20, 2025
November 1, 2025
1.8 years
November 16, 2025
November 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Patient Health Questionnaire-9
PHQ-9 is used to assess the presence and severity of depressive symptoms.
6 weeks
Geriatric Depression Short From
GDS short is a brief, self-report screening tool designed to identify depressive symptoms in older adults.
6 Weeks
The Generalized Anxiety Disorder-7
GAD-7 is used to assess the severity of generalized anxiety symptoms
6 weeks
General Anxiety Scale-10
The GAS-10 is designed to assess the severity of general anxiety symptoms
6 Weeks
Pre-death grief-12
The PG-12 examines pre-death grief for persons with life limiting illnesses and their care partners.
6 weeks
Secondary Outcomes (8)
Dyadic Coping Inventory
6 Weeks
Short Form Health Survey (SF-12)
6 Weeks
Purpose in Life Scale
6 Weeks
Herth Hope Index
6 Weeks
Inclusion of Other in the Self Scale
6 Weeks
- +3 more secondary outcomes
Study Arms (1)
Acceptance Commitment Therapy
EXPERIMENTALAcceptance and Commitment Therapy (ACT) is a form of cognitive-behavioral therapy that aims to enhance psychological flexibility through six core processes: acceptance, cognitive defusion, being present, self-as-context, values clarification, and committed action. Rather than attempting to eliminate difficult thoughts and feelings, ACT encourages individuals to accept them while committing to behavior changes consistent with their personal values.
Interventions
Acceptance and Commitment Therapy (ACT) is a form of cognitive-behavioral therapy that aims to enhance psychological flexibility through six core processes: acceptance, cognitive defusion, being present, self-as-context, values clarification, and committed action. Rather than attempting to eliminate difficult thoughts and feelings, ACT encourages individuals to accept them while committing to behavior changes consistent with their personal values.
Eligibility Criteria
You may qualify if:
- MMSE= 21-27
- Able to communicate in English
- Identifies as a care partner of a person with MNCD
- Able to communicate in English
- MMSE= 28-30
- Is a family member or friend of the person with MNCD
You may not qualify if:
- Currently in an intervention for reducing anxiety or depression related to their dementia
- MMSE= 28+ or less than 21
- MMSE= \<28
- Is a formal (paid) caregiver
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 16, 2025
First Posted
November 20, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
October 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
November 20, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
The investigators will not be providing any individual participant data. It will all be aggregate